These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 14756461

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group.
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
    Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK.
    J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
    [Abstract] [Full Text] [Related]

  • 10. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 11. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
    Dahl R, Stender A, Rak S.
    Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
    [Abstract] [Full Text] [Related]

  • 12. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ, Antvelink JB, Luwema RA.
    Allergol Immunopathol (Madr); 1998 Feb; 26(5):234-40. PubMed ID: 9885731
    [Abstract] [Full Text] [Related]

  • 13. Long-term clinical efficacy of grass-pollen immunotherapy.
    Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria KT.
    N Engl J Med; 1999 Aug 12; 341(7):468-75. PubMed ID: 10441602
    [Abstract] [Full Text] [Related]

  • 14. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E.
    Clin Ther; 2012 Oct 12; 34(10):2072-81. PubMed ID: 23063373
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O.
    J Allergy Clin Immunol; 2005 Sep 12; 116(3):608-13. PubMed ID: 16159631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J, Ribel M, Herold DA.
    Allergy; 2006 Feb 12; 61(2):181-4. PubMed ID: 16409193
    [Abstract] [Full Text] [Related]

  • 19. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE, Mistrello G, Falagiani P, Paolucci C, Breda D, Roncarolo D, Zanotta S, Monasterolo G, Rossi RE.
    Ann Allergy Asthma Immunol; 2008 Apr 12; 100(4):343-50. PubMed ID: 18450120
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.